Showing results (2281-2290 of 2,647) with videos related to

Sort By:
Pageof 265
Cancer Research|June 18, 2024
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1Mahsa Shirani, Solomon Levin, Bassem Shebl, et al.
Plant Biotechnology Journal|April 9, 2026
Rice EMF3 Alleles Adjust Flower Opening Time to Enhance the Seed Setting Rate Under High Temperature StressTakuma Ishizaki, Yoichi Hashida, Hideyuki Hirabayashi, et al.
Gut|October 16, 2016
Molecular classification of Crohn's disease reveals two clinically relevant subtypesMatthew Weiser, Jeremy M Simon, Bharati Kochar, et al.
Contemporary Clinical Trials|October 31, 2017
Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial)Sheila A M Rauch, Naomi M Simon, H Myra Kim, et al.
JCI Insight|September 8, 2022
Targeting BCL-XL in fibrolamellar hepatocellular carcinomaBassem Shebl, Denise Ng, Gadi Lalazar, et al.
The Journal of Pathology|July 4, 2020
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissueBrittany M Bowman, Stephanie A Montgomery, Travis P Schrank, et al.
Research Square|June 30, 2025
Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophyFlorian Gerstner, Sandra Wittig, Christian Menedo, et al.
European Journal of Immunology|May 10, 2016
Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responsesJeremy M Simon, James P Davis, Saangyoung E Lee, et al.
BMC Medicine|November 16, 2013
Criteria for the use of omics-based predictors in clinical trials: explanation and elaborationLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Pageof 265